OTC Product News (November 2016)

Pharmacy Times, November 2016 Cough, Cold, & Flu, Volume 82, Issue 11

Read about the new OTC Products featured in November.

BIOFREEZEMARKETED BY: Performance Health

Biofreeze by Performance Health is now available for consumer retail. The topical pain reliever is formulated to be a safe and effective pain relief alternative for individuals with backaches, arthritis, sore muscles and joints, sprains, and strains.

FOR MORE INFORMATION: performancehealth.com

FLONASE SENSIMISTMARKETED BY: GSK Consumer Healthcare

The FDA has approved Flonase Sensimist Allergy Relief as an OTC treatment for symptoms associated with seasonal and perennial allergies. Flonase was previously available by prescription as Veramyst. It will be nationally available in early 2017.

FOR MORE INFORMATION: gsk.com

SINEXMARKETED BY: Vicks

Vicks has announced the relaunch and expansion of its Sinex brand of OTC medications for the treatment of sinus symptoms. Vicks Sinex now offers a complete product lineup with sprays and Liquicaps, including Scent-Free Ultra Fine Mist, Severe Nasal Spray, Severe Ultra Fine Mist, Moisturizing Ultra Fine Mist, Nighttime and Daytime Liquicaps, and Liquicaps Convenience Packs.

FOR MORE INFORMATION: vicks.com/sinex

MORNING AFTERMARKETED BY: Rapha Pharmaceuticals, Inc

The FDA has approved the use of Morning After, a new brand of emergency contraceptive, as a nonprescription product for women. Morning After reduces the chance of pregnancy and is available as a single-dose 1.5-mg tablet that should be taken as soon as possible within 72 hours after unprotected sex.

FOR MORE INFORMATION: buymorningafter.com